Preterm Birth Diagnostic Test Kits Market Would Reach US$ 200 Mn by 2028, With a CAGR of 7.4% During 2018-2028

Preterm Birth Diagnostic Test Kits Market Would Reach US$ 200 Mn by 2028, With a CAGR of 7.4% During 2018-2028

PR Newswire

VALLEY COTTAGE, New York, October 23, 2018

VALLEY COTTAGE, New York, October 23, 2018 /PRNewswire/ --

A new study by the company titled 'Preterm Birth Diagnostic Test Kits Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028', has listed out the key points being considered by preterm birth diagnostic test kits companies to emerge and stay sustainably profitable in the long run in the preterm birth diagnostic test kits market. The global preterm birth diagnostic test kits market is expected to expand at a CAGR of 7.4% over the forecast period to reach a value of over US$ 200 Mn by 2028, and the North America preterm birth diagnostic test kits market is expected to remain as a main sink market for revenues. Europe is expected to remain as the main source market for preterm birth diagnostic test kits, as most of the preterm birth diagnostic test kits facilities are located in this region. However, with the increasing demand and cost-effective diagnostic options in countries such as China and India, and various countries of Asia Pacific and Middle-East, is fueling the growth of preterm birth diagnostic test kits market.

     (Logo: https://mma.prnewswire.com/media/677274/Future_Market_Insights_Logo.jpg )

Key Findings Presented in the Report on the Preterm Birth Diagnostic Test Kits Market  

The report finds that approximately 115.4 million births occurred in 2017, out of which 11.1% births were preterm, which is approximately 12.8 million births. As per WHO, preterm birth complications are the leading cause of deaths amongst children under the age of 5, directly responsible for approximately 1 million death in 2015. Out of these, 3/4th of these deaths can be prevented with cost-effective interventions. The adoption rates for preterm birth diagnostic tests kits ranged from 2% to 15% distributed over various geographies. Majority of the existent patient pool are unaware about the cost-saving benefits of preterm birth diagnostic test kits, thus, a major portion on the preterm birth test kits market has remained untapped which remains open for manufactures of preterm diagnostic test kits to exploit the preterm birth diagnostic test kits market over the forecast period.

A sample of this report is available upon request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7551

Analysis of the Preterm Birth Diagnostic Test Kits Market 

For preterm birth diagnostic test kits, blood sample is the most common sample take for diagnosing preterm labor and premature rupture of membrane. Blood sample-based preterm birth diagnostic tests in preterm cases are the most common and widely accepted in the preterm birth diagnostic test kits end users. However, vaginal discharge sample type preterm birth diagnostic tests are gaining popularity for preterm birth diagnostic test kits.

Hospitals, outpatient clinics & diagnostic laboratories using preterm birth diagnostic tests are the primary point of contact for patients experiencing preterm birth symptoms. Hospitals are estimated to account for majority of the revenue share under the end users segment for preterm birth diagnostic test kits market in 2017, owing to being the primary healthcare facility for preterm cases. The prevalent cases of preterm birth, growing demand for cost-effective diagnostic options and preterm birth test kits, and success in clinical studies for developing a rapid preterm birth diagnostic test kits is expected to fuel the growth of the global preterm birth diagnostic test kits market over the forecast period.

Activities across the preterm birth diagnostic test kits manufacturers are restricted to efficiency and specificity testing. The top activity associated with preterm birth diagnostic test kits manufacturers is joint collaboration with various organizations in order to spread awareness, further development, and test the sensitivity, specificity and efficiency of preterm birth diagnostic test kits.

Preview Analysis On Preterm Birth Diagnostic Test Kits Market Segmenatation By Product Type - Fetal Fibronectin Test Kits (fFN), Placental Alpha Micro-globulin-1 test kits (PAMG-1), Binding Protein-1 test kits (IGFBP-1); Sample Type - Blood sample, urine sample, and vaginal discharge sample: https://www.futuremarketinsights.com/reports/preterm-birth-diagnostic-test-kits-market

Factors Impacting Growth of the Preterm Birth Diagnostic Test Kits Market 

Rising focus on cost-effective diagnosis using preterm birth diagnostic test kits is expected to boost the growth of the preterm birth diagnostic test kits market. Preterm birth diagnostic test kits manufacturing companies focusing on spreading awareness about preterm birth diagnostic test kits and marketing preterm birth diagnostic test kits through campaigns and joint research studies is expected fuel the growth of the preterm birth diagnostic test kits market during the forecast period. However, Preterm birth diagnostic kits experience stiff competition from alternative product lines. Trans-vaginal scans, advanced ultrasound are some of the examinations adopted by healthcare providers over preterm birth diagnostic kits and would pose challenges to the growth of the preterm birth diagnostic test kits market.

Ask questions to Expert @: https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-7551

Preterm Birth Diagnostic Test Kits Market: Companies 

Some of the key preterm birth diagnostic test kits companies analyzed in this report titled Preterm birth diagnostic test kits market include Creative Diagnostics, Qiagen, Medixbiochemcia, Hologic Inc, Sera Prognostics, IQ Products, Biosynex, Nanjing Liming Biological Preparations Co Ltd, Clinical Innovations LLC, BIOSERV Diagnostics GmbH, Wuxi BioHermes Biomedical Technology Co. Ltd, and Anhui Deep Blue Medical Technology.

Get full Report Now: https://www.futuremarketinsights.com/checkout/7551

More from Healthcare, Pharmaceuticals and Medical devices: 

About Us 

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Browse More Healthcare, Pharmaceuticals and Medical devices

Contact Us
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
T (UK): + 44(0)20-7692-8790
Sales: sales@futuremarketinsights.com

Press Office: Press@futuremarketinsights.com 
FMI Blog: http://www.fmiblog.com/ 
Website: http://www.futuremarketinsights.com


Voltar noticias em Inglês